Skip to Content
Cancer Therapy Evaluation Program (CTEP)
Contact NExT
Show menu
Search this site
Last Updated: 05/31/18

Jeff Moscow, MD

Jeff Moscow, MD

Branch Chief

Jeffrey A. Moscow, MD, joined the Investigational Drug Branch (IDB) in January 2014 after serving part time since August 2012. He is a graduate of Harvard University and the Geisel School of Medicine at Dartmouth. He completed his pediatric residency at the University of Texas Southwestern in Dallas and a fellowship in pediatric hematology-oncology in the Pediatric Oncology Branch, NCI. Prior to joining CTEP, he was Children's Miracle Network Professor of Pediatrics, Chief of Pediatric Hematology-Oncology, Vice Chair of Pediatrics, and co-leader of the Experimental Therapeutics Program of the Markey Cancer Center, all at the University of Kentucky. His IDB portfolio includes lapatinib, osimertinib, dinutuximab, MEDI570 and anetumab. Dr. Moscow is also the program director of both the Early Drug Development Opportunity Program, a program that helps involve all NCI Cancer Centers in clinical ETCTN research and PDXNet, a Precision Medicine initiative to systematically incorporate patient-derived models into NCI's preclinical drug development efforts. In addition, Dr. Moscow has a laboratory research program in the Urologic Oncology Branch in the NCI Center for Cancer Research that is focused on targeting metabolic pathways for cancer therapy.

Contact Information:
National Cancer Institute
9609 Medical Center Dr., MSC 9739
For USPS: Bethesda, MD 20892-9739
For Express and Courier: Rockville, MD 20850
Phone: 240-276-6565
Fax: 240-276-7894
E-mail: jeffrey.moscow@nih.gov

About the Branch Chief

Jeffrey A. Moscow, MD Jeffrey A. Moscow, MD, joined the Investigational Drug Branch (IDB) in January 2014 after serving part time since August 2012. He is a graduate of Harvard University and the Geisel School of Medicine at Dartmouth. He completed his pediatric residency at the University of Texas Southwestern in Dallas and a fellowship in pediatric hematology-oncology in the Pediatric Oncology Branch, NCI. More…